Table of Contents Drugs for Solid Tumors Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Drugs for Solid Tumors 1.1 Drugs for Solid Tumors Market Overview 1.1.1 Drugs for Solid Tumors Product Scope 1.1.2 Market Status and Outlook 1.2 Global Drugs for Solid Tumors Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Drugs for Solid Tumors Market by Type 1.3.1 Global Drugs for Solid Tumors Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Drugs for Solid Tumors Revenue Market Share by Type in 2018 1.3.3 Small Molecules 1.3.4 Biologics 1.4 Drugs for Solid Tumors Market by End Users/Application 1.4.1 Hospitals 1.4.2 Clinics 1.4.3 Academic and Research Institutes 2 Global Drugs for Solid Tumors Competition Analysis by Players 2.1 Global Drugs for Solid Tumors Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 Hoffmann-La Roche 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Celgene 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Johnson & Johnson 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Pfizer 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 BMS 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Eli Lilly 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 GSK 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Merck 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Sanofi 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Drugs for Solid Tumors Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 AbbVie 3.12 AstraZeneca 3.13 Bayer 3.14 Biogen 3.15 Boehringer Ingelheim 3.16 Boston Biomedical 3.17 Daiichi Sankyo 4 Global Drugs for Solid Tumors Market Size by Type and Application (2014-2019) 4.1 Global Drugs for Solid Tumors Market Size by Type (2014-2019) 4.2 Global Drugs for Solid Tumors Market Size by Application (2014-2019) 4.3 Potential Application of Drugs for Solid Tumors in Future 4.4 Top Consumer/End Users of Drugs for Solid Tumors 5 North America Drugs for Solid Tumors Development Status and Outlook 5.1 North America Drugs for Solid Tumors Market Size (2014-2019) 5.2 North America Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 5.3 North America Drugs for Solid Tumors Market Size by Application (2014-2019) 6 Europe Drugs for Solid Tumors Development Status and Outlook 6.1 Europe Drugs for Solid Tumors Market Size (2014-2019) 6.2 Europe Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 6.3 Europe Drugs for Solid Tumors Market Size by Application (2014-2019) 7 China Drugs for Solid Tumors Development Status and Outlook 7.1 China Drugs for Solid Tumors Market Size (2014-2019) 7.2 China Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 7.3 China Drugs for Solid Tumors Market Size by Application (2014-2019) 8 Rest of Asia Pacific Drugs for Solid Tumors Development Status and Outlook 8.1 Rest of Asia Pacific Drugs for Solid Tumors Market Size (2014-2019) 8.2 Rest of Asia Pacific Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Drugs for Solid Tumors Market Size by Application (2014-2019) 9 Central & South America Drugs for Solid Tumors Development Status and Outlook 9.1 Central & South America Drugs for Solid Tumors Market Size (2014-2019) 9.2 Central & South America Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Drugs for Solid Tumors Market Size by Application (2014-2019) 10 Middle East & Africa Drugs for Solid Tumors Development Status and Outlook 10.1 Middle East & Africa Drugs for Solid Tumors Market Size (2014-2019) 10.2 Middle East & Africa Drugs for Solid Tumors Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Drugs for Solid Tumors Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Drugs for Solid Tumors Market Size by Regions (2019-2025) 11.1.1 North America Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.1.2 Europe Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.1.3 China Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Drugs for Solid Tumors Revenue and Growth Rate (2019-2025) 11.2 Global Drugs for Solid Tumors Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Drugs for Solid Tumors Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Drugs for Solid Tumors Market Size (Million USD) Status and Outlook (2014-2025) Table Global Drugs for Solid Tumors Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Drugs for Solid Tumors Market Share by Regions (2014-2019) Figure North America Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure China Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Drugs for Solid Tumors Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Drugs for Solid Tumors Market Share by Type in 2018 & 2025 Figure Small Molecules Market Size (Million USD) and Growth Rate (2014-2019) Figure Biologics Market Size (Million USD) and Growth Rate (2014-2019) Table Global Drugs for Solid Tumors Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Drugs for Solid Tumors Market Share by Application in 2018 & 2025 Figure Drugs for Solid Tumors Market Size (Million USD) and Growth Rate in Hospitals (2014-2019) Figure Drugs for Solid Tumors Market Size (Million USD) and Growth Rate in Clinics (2014-2019) Figure Drugs for Solid Tumors Market Size (Million USD) and Growth Rate in Academic and Research Institutes (2014-2019) Table Global Drugs for Solid Tumors Revenue (Million US$) by Players (2014-2019) Table Global Drugs for Solid Tumors Revenue Market Share by Players (2014-2019) Eigure Drugs for Solid Tumors Market Size Share by Players in 2018 Table Global Drugs for Solid Tumors Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Drugs for Solid Tumors Market Share in 2018 Figure Global Top 10 Players Drugs for Solid Tumors Market Share in 2018 Table Drugs for Solid Tumors Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table Hoffmann-La Roche Basic Information List Table Hoffmann-La Roche Description and Business Overview Table Hoffmann-La Roche Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Hoffmann-La Roche (2014-2019) Table Hoffmann-La Roche Drugs for Solid Tumors Recent Developments Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Novartis (2014-2019) Table Novartis Drugs for Solid Tumors Recent Developments Table Celgene Basic Information List Table Celgene Description and Business Overview Table Celgene Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Celgene (2014-2019) Table Celgene Drugs for Solid Tumors Recent Developments Table Johnson & Johnson Basic Information List Table Johnson & Johnson Description and Business Overview Table Johnson & Johnson Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Johnson & Johnson (2014-2019) Table Johnson & Johnson Drugs for Solid Tumors Recent Developments Table Pfizer Basic Information List Table Pfizer Description and Business Overview Table Pfizer Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Pfizer (2014-2019) Table Pfizer Drugs for Solid Tumors Recent Developments Table BMS Basic Information List Table BMS Description and Business Overview Table BMS Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of BMS (2014-2019) Table BMS Drugs for Solid Tumors Recent Developments Table Eli Lilly Basic Information List Table Eli Lilly Description and Business Overview Table Eli Lilly Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Eli Lilly (2014-2019) Table Eli Lilly Drugs for Solid Tumors Recent Developments Table GSK Basic Information List Table GSK Description and Business Overview Table GSK Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of GSK (2014-2019) Table GSK Drugs for Solid Tumors Recent Developments Table Merck Basic Information List Table Merck Description and Business Overview Table Merck Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Merck (2014-2019) Table Merck Drugs for Solid Tumors Recent Developments Table Sanofi Basic Information List Table Sanofi Description and Business Overview Table Sanofi Drugs for Solid Tumors Products, Services and Solutions Table Revenue (Million US$) in Drugs for Solid Tumors Business of Sanofi (2014-2019) Table Sanofi Drugs for Solid Tumors Recent Developments Table AbbVie Basic Information List Table AstraZeneca Basic Information List Table Bayer Basic Information List Table Biogen Basic Information List Table Boehringer Ingelheim Basic Information List Table Boston Biomedical Basic Information List Table Daiichi Sankyo Basic Information List Table Global Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$) Figure Global Drugs for Solid Tumors Revenue Market Share by Type in 2018 Table Global Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure Global Drugs for Solid Tumors Revenue Market by Application in 2018 Table Top Consumer/End Users of Drugs for Solid Tumors Figure North America Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table North America Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure North America Drugs for Solid Tumors Market Size Share by Players in 2018 Table North America Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure North America Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure North America Drugs for Solid Tumors Market Size Share by Application in 2018 Figure Europe Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure Europe Drugs for Solid Tumors Market Size Share by Players in 2018 Table Europe Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure Europe Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure Europe Drugs for Solid Tumors Market Size Share by Application in 2018 Figure China Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table China Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure China Drugs for Solid Tumors Market Size Share by Players in 2018 Table China Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure China Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure China Drugs for Solid Tumors Market Size Share by Application in 2018 Figure Rest of Asia Pacific Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Drugs for Solid Tumors Market Size Share by Players in 2018 Table Rest of Asia Pacific Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Drugs for Solid Tumors Market Size Share by Application in 2018 Figure Central & South America Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure Central & South America Drugs for Solid Tumors Market Size Share by Players in 2018 Table Central & South America Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure Central & South America Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure Central & South America Drugs for Solid Tumors Market Size Share by Application in 2018 Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Drugs for Solid Tumors Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Drugs for Solid Tumors Market Size Share by Players in 2018 Table Middle East & Africa Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Drugs for Solid Tumors Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Drugs for Solid Tumors Market Size Share by Application in 2018 Figure Global Drugs for Solid Tumors Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Drugs for Solid Tumors Market Size by Regions (2019-2025) (Million US$) Figure Global Drugs for Solid Tumors Market Size Share by Regions (2019-2025) Figure Global Drugs for Solid Tumors Market Size Share by Regions in 2025 Figure North America Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Figure China Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Drugs for Solid Tumors Revenue (Million USD) and Growth Rate (2019-2025) Table Global Drugs for Solid Tumors Market Size by Application (2019-2025) (Million USD) Figure Global Drugs for Solid Tumors Market Size by Application (2019-2025) Figure Global Drugs for Solid Tumors Market Size by Application in 2025 Table Global Drugs for Solid Tumors Market Size by Type (2019-2025) (Million US$) Figure Global Drugs for Solid Tumors Market Size by Type (2019-2025) Figure Global Drugs for Solid Tumors Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Hoffmann-La Roche Novartis Celgene Johnson & Johnson Pfizer BMS Eli Lilly GSK Merck Sanofi AbbVie AstraZeneca Bayer Biogen Boehringer Ingelheim Boston Biomedical Daiichi Sankyo